30 Sept 2026, 12:02
Company UpdateMS
VFYVITRAFY LIFE SCIENCES LIMITED
Announcement history available from 1 August 2025
Fromto
4 Sept 2026, 17:10
OtherMS
2 Sept 2026, 09:17
Company UpdateMS
4 Aug 2026, 08:23
Company Administration—
4 Aug 2026, 08:23
Company Administration—
4 Aug 2026, 08:23
Financial ResultsMS
4 Aug 2026, 08:22
Financial ResultsMS
3 Aug 2026, 13:36
Presentations—
29 July 2026, 08:29
Quarterly ReportsMS
23 July 2026, 08:29
Company UpdateMS
22 July 2026, 08:26
Securities Administration—
13 July 2026, 11:43
Securities Administration—
10 July 2026, 09:05
Securities Administration—
9 July 2026, 09:31
Director Interests—
9 July 2026, 08:53
Director Interests—
9 July 2026, 08:21
Securities Administration—
8 July 2026, 10:19
Securities Administration—
8 July 2026, 08:25
Capital Raising—
19 June 2026, 08:20
Capital RaisingMS
18 June 2026, 08:22
Securities Administration—
18 June 2026, 08:22
Securities Administration—
12 June 2026, 09:33
Securities Administration—
12 June 2026, 09:33
PresentationsMS
12 June 2026, 09:32
Capital RaisingMS
10 June 2026, 08:32
Trading Halt / SuspensionMS
3 June 2026, 08:20
Presentations—
2 June 2026, 10:08
Company UpdateMS
22 May 2026, 08:23
Presentations—
22 May 2026, 08:23
PresentationsMS
22 May 2026, 08:20
Company UpdateMS
28 Apr 2026, 08:22
Presentations—
28 Apr 2026, 08:21
Quarterly ReportsMS
23 Apr 2026, 16:27
Presentations—
8 Apr 2026, 08:23
Company UpdateMS
26 Mar 2026, 08:14
Presentations—
24 Mar 2026, 17:40
Company Administration—
19 Feb 2026, 11:09
Director Interests—
4 Feb 2026, 08:25
Financial ResultsMS
4 Feb 2026, 08:25
Financial ResultsMS
3 Feb 2026, 08:18
Presentations—
29 Jan 2026, 08:17
Presentations—
29 Jan 2026, 08:17
Quarterly ReportsMS
28 Jan 2026, 14:22
Periodic Reports—
20 Jan 2026, 09:22
Director Interests—
20 Jan 2026, 09:19
Company Administration—
19 Jan 2026, 12:56
Substantial Holders—
15 Jan 2026, 08:28
Company Administration—
15 Jan 2026, 08:24
PresentationsMS
15 Jan 2026, 08:24
Company UpdateMS
15 Dec 2025, 08:48
Director Interests—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 30 Sept 2026, 12:02 | Vitrafy enters partnership with Versiti Blood Health | Company Update | MS | 11001 | |
| 4 Sept 2026, 17:10 | S&P DJI Announces September 2026 Quarterly Rebalance | Other | MS | — | |
| 2 Sept 2026, 09:17 | Vitrafy enters U.S. Cell & Gene Therapy Market | Company Update | MS | 11001 | |
| 4 Aug 2026, 08:23 | FY26 Corporate Governance Statement | Company Administration | — | 03024 | |
| 4 Aug 2026, 08:23 | FY26 Appendix 4G | Company Administration | — | 03025 | |
| 4 Aug 2026, 08:23 | FY26 Full Year Results Presentation | Financial Results | MS | 03003, 03026 | |
| 4 Aug 2026, 08:22 | FY26 Appendix 4E and Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 3 Aug 2026, 13:36 | Vitrafy FY26 Investor Briefing | Presentations | — | 03027, 14014 | |
| 29 July 2026, 08:29 | Q4 FY26 Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19004, 19009 | |
| 23 July 2026, 08:29 | Vitrafy enters a partnership with Hoxworth Blood Center | Company Update | MS | 11001 | |
| 22 July 2026, 08:26 | Application for quotation of securities - VFY | Securities Administration | — | 06020 | |
| 13 July 2026, 11:43 | Notification of cessation of securities - VFY | Securities Administration | — | 06027 | |
| 10 July 2026, 09:05 | Application for quotation of securities - VFY | Securities Administration | — | 06020 | |
| 9 July 2026, 09:31 | Change of Director's Interest Notice - Correction | Director Interests | — | 02009 | |
| 9 July 2026, 08:53 | Change of Director's Interest Notices | Director Interests | — | 02009 | |
| 9 July 2026, 08:21 | Application for quotation of securities - VFY | Securities Administration | — | 06020 | |
| 8 July 2026, 10:19 | Expiry of Voluntary Escrow Restrictions | Securities Administration | — | 06009 | |
| 8 July 2026, 08:25 | Results of Oversubscribed Share Purchase Plan | Capital Raising | — | 06017 | |
| 19 June 2026, 08:20 | Vitrafy Share Purchase Plan Opens - SPP Offer Booklet | Capital Raising | MS | 06017 | |
| 18 June 2026, 08:22 | Cleansing Notice | Securities Administration | — | 06018 | |
| 18 June 2026, 08:22 | Application for quotation of securities - VFY | Securities Administration | — | 06020 | |
| 12 June 2026, 09:33 | Proposed issue of securities - VFY | Securities Administration | — | 06013 | |
| 12 June 2026, 09:33 | Vitrafy Equity Raising Presentation | Presentations | MS | 03026 | |
| 12 June 2026, 09:32 | Vitrafy Placement Completion and SPP Announcement | Capital Raising | MS | 06003, 06017, 09014 | |
| 10 June 2026, 08:32 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 3 June 2026, 08:20 | Vitrafy Investor Presentation | Presentations | — | 03026 | |
| 2 June 2026, 10:08 | Vitrafy enters a partnership with Vitalant Innovation Center | Company Update | MS | 11001 | |
| 22 May 2026, 08:23 | Phase 2 USAISR Platelet Results Investor Briefing | Presentations | — | 14014 | |
| 22 May 2026, 08:23 | Phase 2 USAISR Platelet Results Investor Presentation | Presentations | MS | 03026 | |
| 22 May 2026, 08:20 | Final US Army Phase 2 Platelet Results | Company Update | MS | 11001, 14014 | |
| 28 Apr 2026, 08:22 | Quarterly Investor Briefing Presentation | Presentations | — | 03026 | |
| 28 Apr 2026, 08:21 | Q3 FY26 Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 14014, 19003, 19008 | |
| 23 Apr 2026, 16:27 | Vitrafy Q3 FY26 Investor Briefing | Presentations | — | 03027, 14014 | |
| 8 Apr 2026, 08:23 | USAISR Completes Phase 2 Platelet Study | Company Update | MS | 11001 | |
| 26 Mar 2026, 08:14 | NWR Virtual Healthcare Conference Presentation | Presentations | — | 03026 | |
| 24 Mar 2026, 17:40 | Vitrafy to present at NWR Virtual Healthcare Conference | Company Administration | — | 12008 | |
| 19 Feb 2026, 11:09 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 4 Feb 2026, 08:25 | FY26 Half Year Results Presentation | Financial Results | MS | 03004, 03026 | |
| 4 Feb 2026, 08:25 | FY26 Appendix 4D and Half Year Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 3 Feb 2026, 08:18 | Vitrafy FY26 Half Year Investor Briefing | Presentations | — | 03027, 14014 | |
| 29 Jan 2026, 08:17 | Quarterly Investor Briefing Presentation | Presentations | — | 03026, 19007 | |
| 29 Jan 2026, 08:17 | Q2 FY26 Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 14014, 19002, 19007 | |
| 28 Jan 2026, 14:22 | Vitrafy Q2 FY26 Investor Briefing | Periodic Reports | — | 03027 | |
| 20 Jan 2026, 09:22 | Initial Director's Interest Notice | Director Interests | — | 02008 | |
| 20 Jan 2026, 09:19 | Appointment of Independent Non-Executive Director | Company Administration | — | 12001 | |
| 19 Jan 2026, 12:56 | Change in substantial holding from RYD | Substantial Holders | — | 02002 | |
| 15 Jan 2026, 08:28 | IMV Strategic Commercial Agreement Investor Briefing | Company Administration | — | 12008 | |
| 15 Jan 2026, 08:24 | IMV Strategic Partnership Investor Presentation | Presentations | MS | 03026 | |
| 15 Jan 2026, 08:24 | Vitrafy Enters Strategic Commercial Agreement with IMV | Company Update | MS | 11001 | |
| 15 Dec 2025, 08:48 | Change of Director's Interest Notice | Director Interests | — | 02009 |
1–50 of 68
1 / 2